- Kimberly-Clark Corp KMB reported fourth-quarter FY21 sales growth of 3% year-on-year, to $4.97 billion, beating the analyst consensus of $4.90 billion.
- Organic sales increased 3% as net selling prices rose 2% and product mix increased sales 1%. In North America, organic sales rose 2% in K-C Professional.
- Sales from the personal care segment increased 12%, the consumer tissue segment fell 10%, and K-C Professional climbed 2%.
- Adjusted EPS of $1.30 beat the analyst consensus of $1.25.
- Gross profit fell by 14% Y/Y to $1.44 billion. Marketing, research, and general expenses decreased 9% Y/Y to $911 million.
- Operating income declined 30% to $521 million, with an operating margin of 10.5%.
- Cash provided by operations increased 19.7% to $1.06 billion. The company held $270 million in cash and equivalents as of December 31, 2021.
- "While we expect inflation and supply-chain disruption to persist into 2022, we are committed to recovering margins to pre-pandemic levels over time, and we are optimistic about gradual improvement later in the year," said Chairman and CEO Mike Hsu.
- The company's board has approved a 1.8% increase in the quarterly dividend. The quarterly dividend of $1.16 per share will be payable on April 4 to stockholders of record on March 4.
- Outlook: Kimberly-Clark expects FY22 sales to increase 1% - 2%. The company sees FY22 EPS of $5.60 - $6.00 versus the consensus of $6.70.
- Price Action: KMB shares are trading lower by 5.82% at $131.50 in premarket on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
